Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illumina, Inc. (ILMN) vs Sempra Energy (SRE) Price & Performance

Illumina, Inc.Trade
Sempra EnergyTrade

Price performance (Past 24H)

Key statistics

Illumina, Inc. vs Sempra Energy — how do they compare? Illumina, Inc. trades at $265.87 (market cap $39.95B), while Sempra Energy trades at $80.08 (market cap $52.36B). The key difference: Sempra Energy is the larger of the two by market cap, and Sempra Energy pays a 3.28% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Sempra Energy for 8 Days on average.

ILMNSRE
Market Cap
$39.95B$52.36B
Volume
3,169,5033,338,383
Sector
HealthUtilities
52-Week High
$293.69$99.75
52-Week Low
$91.00$76.90
Typical Hold Time
83 Days8 Days
Enterprise Value
$41.31B$89.00B
Dividend Yield
—3.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illumina, Inc.

Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.

The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.

Sempra Energy

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ILMN
96% Buy4% Sell
Avg holding period · 83 Days
SRE
0% Buy100% Sell
Avg holding period · 8 Days

Top news

Latest headlines on both assets

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN →

About Sempra Energy

Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.

Read more on SRE →